Asia Regulatory Forum Update
This article was originally published in Clinica
"The AHWP is currently looking into becoming a legal entity. This is an important issue that has been on the organisation's agenda since December 2008. Right now, the organisation is purely virtual, and the problem with this is that it means the organisation cannot have its own bank account and effectively manage its funds – which it is receiving at ever-increasing levels.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.